FIELD: biotechnologies.
SUBSTANCE: invention relates to the biotechnology. Invention relates to the influenza virus the virus-like particle (VLP), designed for the anti-influenza vaccine development, constructed from influenza virus proteins: hemagglutinin, neuraminidase and matrix protein M1, where the neuraminidase proteins and matrix protein M1 are the A/California/04/2009 strain proteins, and hemagglutinin is the strain A/California/04/2009, A/Michigan/45/2015(H1N1), A/Novosibirsk/01/2014, A/HongKong/4801/2014(H3N2), B/Phuket/3073/2013 or B/Brisbane/60/2008, and also to its obtaining method.
EFFECT: development of the anti-influenza vaccine.
5 cl, 44 dwg, 6 ex, 15 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| FLU VIRUS PROTEINS PRODUCER MDCK CELL (OPTIONS) | 2018 |
|
RU2681482C1 |
| METHOD OF PRODUCING A POLYVALENT INFLUENZA VACCINE | 2018 |
|
RU2701953C1 |
| MULTIVALENT INFLUENZA VACCINE | 2018 |
|
RU2706191C1 |
| CASSETTE INTENDED FOR OBTAINING PLASMID VECTORS USED TO CREATE CELL PRODUCERS OF VIRUS-LIKE PARTICLES (VLP) OF INFLUENZA VIRUS | 2018 |
|
RU2680703C1 |
| CONCENTRATE OF INFLUENZA VACCINE AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2706544C1 |
| LENTIVIRUS PLASMIDA (OPTIONS), METHOD FOR ITS OBTAINING (OPTIONS), SET OF PRIMERS FOR OBTAINING LENTIVIRUS PLASMID VECTOR (OPTIONS) | 2018 |
|
RU2680537C1 |
| METHOD OF CONTROLLING PRODUCTION OF A VACCINE AGAINST INFLUENZA | 2018 |
|
RU2701959C1 |
| STRAIN OF BACTERIA ESCHERICHIA COLI - PRODUCER OF RECOMBINANT PROTEIN NS1 | 2021 |
|
RU2789735C1 |
| RECOMBINANT STRAIN OF A/PR8-NS124-Luc INFLUENZA VIRUS AND METHOD FOR EVALUATING POST-VACCINAL NEUTRALIZING ANTIBODIES USING BIOLUMINESCENT DETECTION | 2019 |
|
RU2759054C2 |
| RECOMBINANT INFLUENZA VIRUS INTENDED FOR THE PREVENTION OF COVID-19 AND INFLUENZA, METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2802058C1 |
